Details for Patent: 11,541,002
✉ Email this page to a colleague
Which drugs does patent 11,541,002 protect, and when does it expire?
Patent 11,541,002 protects SYMPAZAN and is included in one NDA.
This patent has six patent family members in six countries.
Drugs Protected by US Patent 11,541,002
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-001 | Nov 1, 2018 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | Y | METHOD OF TREATING SEIZURES | ⤷ Subscribe | |||
| Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-002 | Nov 1, 2018 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | Y | METHOD OF TREATING SEIZURES | ⤷ Subscribe | |||
| Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-003 | Nov 1, 2018 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | METHOD OF TREATING SEIZURES | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,541,002
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Brazil | 112021004053 | ⤷ Subscribe | |||
| Canada | 3110997 | ⤷ Subscribe | |||
| China | 112955124 | ⤷ Subscribe | |||
| European Patent Office | 3846778 | ⤷ Subscribe | |||
| Japan | 2021536466 | ⤷ Subscribe | |||
| World Intellectual Property Organization (WIPO) | 2020051317 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
